Starling Medical

Starling Medical develops at-home urine monitoring technology for preventative health management and early intervention. The company's primary product, UrinDx™, is a bathroom-integrated device that analyzes urine samples and transmits health insights to users via a smartphone app and to a dedicated Starling care team for clinical review. The platform targets urology and primary care providers, with a focus on recurrent urinary tract infection (rUTI) prevention and management. UrinDx enables patient-driven monitoring of urinary health patterns, supports antibiotic stewardship, and facilitates early clinical intervention. The program is designed for insurance reimbursement, with most patients paying $0 out-of-pocket. Starling Medical operates a nurse-monitored dashboard and provides care coordination between patients and providers. The company is pursuing FDA clearance for UrinDx. A second product, Pete, is noted as coming soon. The business model emphasizes preventative care delivery without negative impact on provider revenue, with reimbursement available for triage and preventative care services. The platform integrates real-time health insights, symptom tracking, and telehealth appointment scheduling through a unified mobile application.